Participants
Diabetes, diabetes
TYPE 1 DIABETES, DIABETES, DIABETES
Participants were recruited from the outpatient diabetes clinic at Steno Diabetes Center Copenhagen. Key inclusion criteria were age ≥18 years; duration of type 1 diabetes ≥2 years; use of insulin pump therapy (without sensor-augmented insulin suspension/adjustment functionality) for ≥6 months; HbAAll individuals provided oral and written informed consent before commencement of any trial-related activity.